Many of these agents may be restricted to use by infectious-disease physicians or by antimicrobial-stewardship teams, with pharmacists playing an important role.
Antiplatelet and anticoagulant agents are treatment mainstays, and pharmacists play a role in educating and monitoring at-risk patients on pharmacologic as well as nonpharmacologic interventions.